Cartesian Therapeutics Inc (RNAC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -37,726 | -1,824 | -17,710 | -77,424 | -67,171 |
| Depreciation Amortization | 2,351 | 1,745 | 1,156 | 1,151 | 665 |
| Income taxes - deferred | N/A | N/A | N/A | 287 | N/A |
| Accounts receivable | 150 | 518 | -893 | 7,979 | 3,042 |
| Accounts payable and accrued liabilities | 1,999 | 231 | 1,819 | -2,927 | -2,690 |
| Other Working Capital | -8,060 | -8,590 | -7,082 | -5,791 | -12,638 |
| Other Operating Activity | -14,943 | -32,709 | -398 | 53,051 | 62,120 |
| Operating Cash Flow | $-56,229 | $-40,629 | $-23,108 | $-23,674 | $-16,672 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4,962 | -3,670 | -1,075 | -8,742 | -8,388 |
| Investing Cash Flow | $-4,962 | $-3,670 | $-1,075 | $-8,742 | $-8,388 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 273 | 268 | 183 | 128,494 | 3,207 |
| Other Financing Activity | -8,276 | -8,233 | -8,208 | 39,934 | 164,438 |
| Financing Cash Flow | $-8,003 | $-7,965 | $-8,025 | $168,428 | $167,645 |
| Exchange Rate Effect | 34 | 44 | 32 | -21 | -6 |
| Beginning Cash Position | 214,279 | 214,279 | 214,279 | 78,288 | 78,288 |
| End Cash Position | 145,119 | 162,059 | 182,103 | 214,279 | 220,867 |
| Net Cash Flow | $-69,160 | $-52,220 | $-32,176 | $135,991 | $142,579 |
| Free Cash Flow | |||||
| Operating Cash Flow | -56,229 | -40,629 | -23,108 | -23,674 | -16,672 |
| Capital Expenditure | -4,962 | -3,670 | -1,075 | -9,093 | -8,388 |
| Free Cash Flow | -61,191 | -44,299 | -24,183 | -32,767 | -25,060 |